AwardTape · Defense awards · Xequel Bio, Inc
Xequel Bio, Inc: -$550K in DoD and DHS awards
Xequel Bio, Inc holds 1 DoD and DHS prime award with -$550K obligated Jan 16, 2025 to Jan 16, 2025. Largest category: Health R&D at -$550K; largest buyer: Department of the Army at -$550K.
| Obligated FY2024+ | -$550K |
|---|---|
| Awards | 1 |
| FY2024 | $0 |
| FY2025 | -$550K |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $1000K |
| Parent company (as reported) | Xequel Bio, Inc |
| First and latest action | Jan 16, 2025 · Jan 16, 2025 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | -$550K | 1 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | -$550K | 1 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81XWH17C0065 definitive contract | -$550K | Igf::ot::igf DHA sbir ph ii proposal no. a2-6647 | Army | Health R&D | Jan 16, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial